Details for 2022175048
Up to date per 22.04.2026
Actions
Details for 2022175048
Granted/Registered
European Patent
04.01.2023 A
21.01.2026 B1
18.10.2016
US
201662409833 P
07.06.2017
US
201762516594 P
A61K 31/53 20060101AFI20221013BHEP
Owner
Madrigal Pharmaceuticals, Inc.200 Barr Harbor Drive, Suite 400 West Conshohocken, Pennsylvania 19428US
Representative
No representatives present
Inventor
TAUB, Rebecca Villanova, 19085US
Information about Fees